All In Biotech

Drug Trial Radar · NCT01469039

A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia

Last checked: Nov 20, 2026Latest source record: Jan 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 623 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

623

Actual

Start

Dec 2011

Primary completion

Jan 2014

Study completion Mar 2014

Sponsor

Lead sponsor
Alkermes, Inc.Industry
Sponsor type
Industry
First posted
Nov 10, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will determine the efficacy of ALKS 9072 (also known as aripiprazole lauroxil or ALKS 9070) for the treatment of schizophrenia in subjects experiencing an acute exacerbation.

Conditions

  • Schizophrenia

Interventions

  • ALKS 9072Drug

    Intramuscular (IM) injection, 441 mg or 882 mg given monthly

  • PlaceboDrug

    Placebo for IM injection, given monthly

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Change From Baseline at Day 85 in Positive and Negative Syndrome Scale (PANSS) Total ScoreTime frame: Data collected from baseline to day 85

Locations

84 sites in 8 countries. Site status is shown where the registry gives one.

  • Alkermes Investigational Site

    Little Rock, Arkansas

  • Alkermes Investigational Site

    Little Rock, Arkansas

  • Alkermes Investigational Site

    Springdale, Arkansas

  • Alkermes Investigational Site

    Cerritos, California

  • Alkermes Investigational Site

    Garden Grove, California

  • Alkermes Investigational Site

    La Habra, California

  • Alkermes Investigational Site

    Oakland, California

  • Alkermes Investigational Site

    Oceanside, California

  • Alkermes Investigational Site

    Orange, California

  • Alkermes Investigational Site

    San Diego, California

  • Alkermes Investigational Site

    Washington D.C., District of Columbia

  • Alkermes Investigational Site

    Fort Lauderdale, Florida

  • Alkermes Investigational site

    Leesburg, Florida

  • Alkermes Investigational Site

    Atlanta, Georgia

  • Alkermes Investigational Site

    Chicago, Illinois

  • Alkermes Investigational Site

    Hoffman Estates, Illinois

  • Alkermes Investigational Site

    Overland Park, Kansas

  • Alkermes Investigational Site

    Rockville, Maryland

  • Alkermes Investigational Site

    Creve Coeur, Missouri

  • Alkermes Investigational Site

    St Louis, Missouri

  • Alkermes Investigational Site

    Philadelphia, Pennsylvania

  • Alkermes Investigational Site

    Charleston, South Carolina

  • Alkermes Investigational Site

    Austin, Texas

  • Alkermes Investigational Site

    Austin, Texas

  • Alkermes Investigational Site

    Dallas, Texas

  • Alkermes Investigational Site

    Dallas, Texas

  • Alkermes Investigational Site

    Burgas, Bulgaria

  • Alkermes Investigational Site

    Kazanlak, Bulgaria

  • Alkermes Investigational Site

    Novi Iskar, Bulgaria

  • Alkermes Investigational Site

    Pazardzhik, Bulgaria

  • Alkermes Investigational Site

    Pleven, Bulgaria

  • Alkermes Investigational Site

    Plovdiv, Bulgaria

  • Alkermes Investigational Site

    Radnevo, Bulgaria

  • Alkermes Investigational Site

    Rousse, Bulgaria

  • Alkermes Investigational Site

    Sofia, Bulgaria

  • Alkermes Investigational Site

    Stara Zagora, Bulgaria

  • Alkermes Investigational Site

    Targovishte, Bulgaria

  • Alkermes Investigational Site

    Veliko Tarnovo, Bulgaria

  • Alkermes Investigational Site

    Vratsa, Bulgaria

  • Alkermes Investigational Site

    Cheras, Malaysia

Showing 40 of 84 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.